期刊文献+

促红细胞生成素衍生肽抑制缺血/再灌注损伤诱导的大鼠心肌细胞凋亡 被引量:6

Helix B surface peptide is cardioprotective through inhibition on myocardial apoptosis induced by ischemia/reperfusion injury
下载PDF
导出
摘要 目的:探讨促红细胞生成素(erythropoietin,EPO)衍生肽又称螺旋B表面肽(helix B surface peptide,HBSP)在大鼠心肌缺血/再灌注损伤(I/RI)中的拮抗作用及其机制。方法:82只200~250 g雄性SD大鼠随机分为假手术(Sham)组(n=18)、缺血/再灌注(I/R)组(n=18)、EPO组(n=18)、HBSP组(n=18)及HBSP+LY294002(PI3k特异性抑制剂)组(n=10)。于灌注前5 min,于EPO组及HBSP组大鼠的尾静脉分别注射生理盐水重组人EPO(rhEPO;3 000 U/kg,4 ml/kg)及生理盐水HBSP(60μg/kg,4 ml/kg)。颈动脉插管检测血流动力学指标,采用小动物超声分别检测24 h、1周后大鼠心功能。用TTC-EB双染测定梗死面积,Western blot法检测心肌组织蛋白激酶B(Akt)和磷酸化Akt的表达。用TUNEL法检测心肌细胞凋亡。结果:与I/R组相比,EPO组和HBSP组再灌注后大鼠心脏左室收缩压(LVSP)、左室内压最大上升速率(+dp/dtmax)以及最大下降速率(-dp/dtmax)明显改善(P<0.05),左室射血分数[LVEF(%)]、室间隔厚度(IVSS)及左室短轴缩短率[FS(%)]显著增加(P<0.05),同时心肌梗死面积明显缩小(P<0.05),心肌细胞凋亡显著减少(P<0.05);HBSP组Akt磷酸化水平显著提高(P<0.05)。HBSP+LY294002组与HBSP组相比,Akt磷酸化水平明显降低,心肌细胞凋亡指数显著增高(P<0.05)。HBSP组与EPO组间各项指标均无显著差别。结论:HBSP能够显著抑制I/RI诱导的大鼠心肌细胞凋亡,减少梗死面积,明显改善心功能,其保护作用可能与激活PI3K-Akt通路有关。 AIM: To observe the protective effects and mechanism of Helix B surface peptide(HBSP) in rat myocardial ischemia/reperfusion injury.METHODS: Eighty-two Sprague Dawley rats(200-250 g) were randomly divided into five groups: sham group(n=18),ischemia/reperfusion(I/R) group(n=18),erythropoietin(EPO) group(3000 U/kg,4 ml/kg,n=18),HBSP group(60 μg/kg,4 ml/kg,n=18) and HBSP+LY294002 group(n=10).EPO or HBSP was injected from tail veins 5 min before reperfusion.Hemodynamic values were measured via a cannula inserted into the right common carotid artery,and cardiac functions were evaluated by echocardiograph 24 h and 1 week after reperfusion.Infarct size was measured by TTC staining and the area at risk was assessed by Evans blue staining.Expressions of Akt and phospho-Akt were detected by Western blotting and apoptosis of cardiomyocytes was detected by TUNEL.RESULTS: Compared with those in I/R group,hemodynamic values of LVSP and ±dp/dtmax and cardiac functions improved after 24 h and 1 week in EPO group and HBSP group.The infarct size also reduced and cardiomyocyte apoptosis was inhibited.Cardiomyocyte apoptosis was partially inhibited after blocking the levels of PI3K-Akt in HBSP+LY294002 group(P〈0.05).The expressions of phospho-Akt were upregulated by HBSP and the apoptotic index of cardiomyocytes in HBSP+LY294002 group was higher than that in HBSP group(P〈0.05).Hemodynamic values and cardiac functions after 24 h and 1 week in the other groups were lower compared with those in sham-operated group,and the infarct size and apoptotic index of cardiomyocytes were higher than those in sham group(P〈0.05).No statistically significant differences were found between EPO group and HBSP group.CONCLUSION: Helix B surface peptide could markedly improve heart functions and decrease the infarct size and myocardial apoptosis induced by ischemia/reperfusion injury in in vivo rats.Its protective effects may possibly be through the activation of PI3K-Akt signal pathway.
出处 《心脏杂志》 CAS 2013年第3期327-332,共6页 Chinese Heart Journal
关键词 促红细胞生成素 多肽 缺血 再灌注 细胞凋亡 大鼠 erythropoietin polypeptide ischemia/reperfusion apoptosis rat
  • 相关文献

参考文献15

  • 1Fisher JW. Erythropoietin : physiology and pharmacology update[ J ]. Exp Biol Med ( Maywood), 2003, 228 ( 1 ) : 1 - 14.
  • 2Joyeux-Faure M. Cellular protection by erythropoietin: new therapeu- tic implications? [J]. J Pharmoryol Exp Ther, 2007, 323(3) :759 - 762.
  • 3Brines M, Cerami A. Erythropoietin-mediated tissue protection: re- ducing collateral damage from the primary injury responses[ J]. J In- tern Med, 2008, 264(5):405-432.
  • 4Bogoyevitch MA. An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neutoprotection[ J]. Cardiovas Res, 2004, 63(2) :208 -216.
  • 5Imamura R, Okumi M, lsaka Y, et al. Carbamylated erythropoietin improves angiogenesis and protects the kidneys from ischeroia reperfu- sion injury[J]. Cell Transplant, 2008, 17( 1 -2) :135 - 141.
  • 6Wang Y, Zhang ZG, Rhodes K, et al. Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ische- rnia[ J]. Br J Pharmacol, 2007, 151 (8) :1377 - 1384.
  • 7Brines M, Patel NS, Villa P, et al. Nonerythropoietic, tissue-protec- tive peptides derived from the tertiary structure of erythropoietin[ J ]. Proc Nat Acad Sci USA, 2008, 105 ( 31 ) : 10925 - 10930.
  • 8赵天,杨橙,胡林昆,许明,林淼,薛寅佳,谢勇威,戎瑞明,朱同玉.促红细胞生成素衍生肽的制备和鉴定及对大鼠肾缺血再灌注损伤的保护作用[J].中国临床医学,2011,18(1):25-28. 被引量:6
  • 9Ahmet I, Tae HJ, Juhaszova M, et al. A Small Nonerythropoietic Helix B surface peptide basedupon erythropoietin structure is cardio- protective against ischemic myocardial damage[ J ]. Mol Med, 2011 , 17(3 -4) 194 -200.
  • 10Siren AL, Knerlich F, Poser W, et al. Erythropoietin and erythro- poietin receptor in human ischemic/hypoxic brain [ J ]. Acta Neuro- pathol, 2001, 101(3) :271 -276.

二级参考文献9

  • 1Yazihan N, Ataoglu H, Kavas GO, et al. The effect of KATP channel blockage during erythropoietin treatment in renal ischemia reperfusion injury[J]. J Invest Surg, 2008, 2I (6):340-347.
  • 2Kiris I, Kapan S, Kilbas A, et al. The protective effect oferythropoietin on renal injury induced by abdominal aorticischemiareperfusion in rats[J]. J Surg Res, 2008, 149(2) :206-213.
  • 3Brines M, Patel NS, Villa P, et al. Nonerythropoietic, tissue-protective peptides derived from the tertiary structure oferythropoietin[J]. Proc Natl Acad Sci U S A, 2008, 105(31):10925-10930.
  • 4Yang C, Hu L, Zhao T, et zl. Protective effect of recombinant human erythropoietin on renal ischemia-reperfusion injury in rats[J]. Fudan Univ J Med Sci, 2010, 37(5) :539-543.
  • 5Yuan R, Maeda Y, Li W, et al. Erythropoietin: a potent inducer of peripheral immuno/inflammatory modulation in autoimmune EAE[J]. PLoS One, 2008, 3(4) : 1924.
  • 6Jubinsky PT, Krijanovski 0I, Nathan DG, et al. The betachain of the interleukin-3 receptor functionally associates withthe erythropoietin receptor[J]. Blood, 1997, 90 (5): 1867-1873.
  • 7Blake TJ, Jenkins BJ, IYAndrea RJ, et al. Functional cross-talk between cytokine receptors revealed by activating mutations in the extracellular domain of the beta-subunit of theGM-CSF receptor[J]. J Leukoc Biol, 2002, 72 (6): 1246-1255.
  • 8Leist M, Ghezzi P, Grasso G, et al. Derivatives of erythropoietin that are tissue protective but not erythropoietic[J]. Seience, 2004, 305(5681):239-242.
  • 9Brines M, Cerami A. Erythropoietinmediated tissue protection: reducing collateral damage from the primary injury re-sponse[J]. J Intern Med, 2008, 264(5):405-432.

共引文献5

同被引文献79

  • 1Masato Kato,Tokihiko Sawada,Junji Kita,Mitsugi Shimoda,Keiichi Kubota.Erythropoietin ameliorates early ischemia-reperfusion injury following the Pringle maneuver[J].World Journal of Gastroenterology,2010,16(38):4838-4845. 被引量:11
  • 2Marie-Louise Ward,David J Crossman.Mechanisms underlying the impaired contractility of diabetic cardiomyopathy[J].World Journal of Cardiology,2014,6(7):577-584. 被引量:13
  • 3Imamura R, Okumi M, Isaka Y, et al. Carbamylated erythropoietin improves angiogenesis and protects the kidneys from ischemia reperfusion injury. Cell Transplant, 2008, 17: 135-141.
  • 4Brines M, Patel NS, Villa P, et al. Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc Natl Acad Sci USA, 2008, 105: 10925-10930.
  • 5Wei L, Sun D , Yin z, et al. A PKC-beta inhibitor protects against cardiac microvascula ischemia reperfusion injury in diabetic Apoptosis, 2010, 15: 488-498.
  • 6Li J, Zhang H, Wu F, et al. Insulin inhibits tumor necrosis factor- α induction in myocardial isehemia/reperfusiou: role of Akt and endothelial nitric oxide synthase phosphorylation. Crit Care Med, 2008, 36: 1551-1558.
  • 7Wang J, Hong Z, Zeng C, et al. NADPH oxidase 4 promotes cardiac microvascular angiogenesis after hypoxia/reoxygenation in vitro. Free Radic Biol Med, 2014, 69: 278-288.
  • 8Su TF, Zhao YQ, Zhang LH, et al. Eleciroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB2 receptors. Eur J Pain, 2012, 16: 624-635.
  • 9Buja LM. Myocardial isehemia and reperfusion injury. Cardiovasc Pathol, 2005, 14: 170-175.
  • 10Yuan R, Maeda Y, Li W, et al. Erythropoietin:a potent inducer of peripheral immune/inflammtory modulation in autoimmune EAE. PIoS one, 2008, 3: 1924.

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部